NaNose cancer detector is ready to market

In international trials, the lung cancer detector developed by Technion’s Dr. Hossam Haick correctly diagnosed early-stage malignant tumors 90% of the time – far better than previous methods. The device has been licensed to Boston’s Alpha Szenszor, for development to market.
http://www.timesofisrael.com/technions-nanose-catches-lung-cancer-90-of-the-time/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.